KRISANA KRAMSEANG: Open Payments
NPI 1881995496 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,520 in 15 payments from 11 companies in 2025. Trend: 2023 $1,359 · 2024 $1,585 · 2025 $1,520
Food & beverage: $1,520
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 2 | $248 |
| ABBVIE INC. | 2 | $213 |
| Madrigal Pharmaceuticals | 1 | $137 |
| GENZYME CORPORATION | 1 | $134 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Ipsen Biopharmaceuticals, Inc | 1 | $121 |
| Janssen Biotech, Inc. | 1 | $121 |
| SANOFI-AVENTIS U.S. LLC | 1 | $119 |
| Sage Therapeutics, LLC | 1 | $109 |
| Exact Sciences Corporation | 2 | $99 |
Products named: VYVGART, REZDIFFRA, LINZESS, AMVUTTRA, IQIRVO, TREMFYA, TZIELD, Cologuard Collection Kit.
Industry payments across OH — which companies pay providers there.
